Q4 2025 FMC Corp Earnings Call Transcript
Key Points
- FMC Corp (FMC) announced a strategic review to explore options, including a potential sale, to maximize shareholder value.
- The company is targeting a $1 billion debt reduction through asset sales and licensing agreements, including the sale of its India commercial business.
- FMC Corp (FMC) is focusing on improving the competitiveness of its core portfolio by lowering manufacturing costs by at least 35% by 2027.
- The company is committed to driving growth of new active ingredients, with sales of these ingredients expected to reach between $300 million and $400 million in 2026.
- FMC Corp (FMC) has a robust R&D pipeline, which is seen as a significant competitive advantage, with expectations of substantial sales growth through application on additional crops.
- FMC Corp (FMC) is facing intense competition from generics, impacting the timing of purchases and product mix for crop protection.
- The company reported a decline in fourth-quarter sales, which came in below guidance, driven by lower Rynaxypyr prices and strong market competition.
- FMC Corp (FMC) expects a 5% decline in full-year sales for 2026, with price being a mid-single-digit headwind.
- The company anticipates a significant reduction in first-quarter adjusted EBITDA, down 58% from the prior year, due to lower prices and unfavorable manufacturing costs.
- FMC Corp (FMC) is experiencing challenges with its core portfolio, particularly in high-cost manufacturing facilities, which are not cost-competitive against generics.
Good morning, and welcome to the fourth-quarter 2025 earnings call for the FMC Corporation. This event is being recorded. I would now like to turn the conference over to Mr. Curt Brooks, Director of Investor Relations for FMC Corporation. Please go ahead.
Good morning, and welcome to FMC Corporation's fourth-quarter earnings call. Joining me today to provide today's prepared remarks are Pierre Brondeau, Chairman, Chief Executive Officer and President; and Andrew Sandifer, Executive Vice President and Chief Financial Officer. After their comments, we will take questions. Our earnings release and today's slide presentation are available on the FMC Investor Relations website, and the prepared remarks from today's discussion will be made available after the call.
Let me remind you that today's presentation nd discussion will include forward-looking statements that are subject to various risks and uncertainties concerning specific factors, including, but not limited to, those factors identified in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
